Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
RGNX compared with FATE: revenue, margins and what each company keeps, and the suppliers and customers both name
RGNX
Regenxbio Inc.
Change
Mkt cap
Revenue
Revenue
FATE
Fate Therapeutics Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
RGNX
Regenxbio Inc.
vs
FATE
Fate Therapeutics Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
RGNX, solid
FATE, dashed
RGNX
Regenxbio Inc.
Change
7.29
▲
+1.20%
Mkt cap
$475.3M
Revenue
$108M
Q2 FY26
Revenue
$170M
FY25
FATE
Fate Therapeutics Inc
Change
2.07
▼
−0.51%
Regular session
Sep 2 '83
Mkt cap
$249.2M
Revenue
$2M
Q2 FY26
Revenue
$7M
FY25
vs
Compare
Regular session
Sep 2 '83
RGNX
Regenxbio Inc.
vs
FATE
Fate Therapeutics Inc
7.29
▲
+1.20%
Price
2.07
▼
−0.51%
$475.3M
Mkt cap
$249.2M
Q2 FY26
$108M
Revenue
$2M
Q2 FY26
FY25
$170M
Revenue
$7M
FY25
Change
Change
RGNX
7.29
▲
+1.20%
vs
FATE
2.07
▼
−0.51%
Regular session
Sep 2 '83